Panmigran (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol, the active ingredient in Panmigran, is an analgesic presented as a combination tablet for oral use. It treats migraine, tension-type headache and other mild to moderate pain in adults. GNH USA supplies Panmigran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Panmigran is a combination analgesic that acts on headache‑related pain pathways. - Migraine: provides relief of moderate migraine attacks when taken at onset. - Tension‑type headache: reduces pain intensity and improves functional ability. - Mild to moderate pain: alleviates discomfort from musculoskeletal or dental sources.

Adverse reactions may range from mild to serious and should be monitored during therapy.

Common Side Effects: - Nausea or upset stomach. - Heartburn or dyspepsia. - Headache that persists despite treatment. - Dizziness or light‑headed feeling. - Increased urinary frequency.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Allergic reactions such as rash, itching or swelling. - Severe liver injury, particularly with overdose. - Asthma exacerbation triggered by aspirin sensitivity. - Unexplained bruising or bleeding abnormalities.

Before using Panmigran, consider the following safety points: - Assess risk of gastro‑intestinal bleeding: patients with a history of ulcers should use caution. - Evaluate renal function: impaired kidneys may affect drug clearance. - Review cardiovascular risk factors: aspirin can influence platelet function. - Check allergy history: avoid if known hypersensitivity to any component. - Store below 25°C: keep in the original packaging ​

Panmigran may interact with several medication classes.

Major Interactions (​​ ​): -  ")."  

---

---  

"  " " " " "" ".

" " \\